Signaling Pathways - Prostate Cancer - Neurocognitive Disorders
清除全部
- A8233 DMXAA (Vadimezan)2 Citation中文名: 2,5-己酮可可碱Target: DT-diaphorasesSummary: 肿瘤血管破坏剂,细胞凋亡诱导剂。
- A8219 Gefitinib (ZD1839)3 Citation中文名: 吉非替尼Target: EGFRSummary: EGFR抑制剂
- A3927 VS-5584 (SB2343)Target: PI3K|mTORSummary: MTOR/P13K抑制剂
- A3872 TH-302Summary: 低氧激活的前体药物,抑制H460/HT29细胞生长
- A3818 SilvestrolSummary: 抗肿瘤药
- A3543 LDE225 DiphosphateTarget: SmoothenedSummary: Smo拮抗剂
- A3449 GSK3431 CitationTarget: EZH2Summary: EZH2抑制剂
- A3433 Gefitinib hydrochloride中文名: 盐酸吉非替尼Target: EGFRSummary: EGFR有效的抑制剂
- A3420 FMKTarget: Ribosomal s6 kinases (RSK)Summary: RSK抑制剂
- A4383 Tolcapone中文名: 托卡朋Target: Catechol O-Methyltransferase (COMT)Summary: COMT抑制剂